Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas.

作者: R. Bettini , W. Mantovani , L. Boninsegna , S. Crippa , P. Capelli

DOI: 10.1016/J.DLD.2008.03.015

关键词: PancreatectomyDebulkingPancreaticoduodenectomyOncologyGastroenterologyInternal medicineCarcinomaProliferative indexProliferation indexSurvival analysisMedicineUnresected

摘要: Abstract Background The role of debulking surgery in metastatic nonfunctioning pancreatic endocrine carcinomas (M-NF-PECs) with resectable primary tumour and unresectable liver metastases is debated. Aim the study to evaluate whether resection carcinoma improves survival. Patients methods Fifty-one patients were enrolled from 1990 2004 at time diagnosis. Nineteen underwent complete whilst 32 judged unresectable. All cases classified according WHO 2000 classification. clinico-pathological parameters, including grade differentiation Ki-67 proliferation index considered univariate multivariate models. Results Of 19 resected patients, 14 (73.7%) left-pancreatectomy 5 (26.3%) pancreaticoduodenectomy. In unresected group 9 (28.1%) surgical biliary and/or gastric by-pass. There was no postoperative mortality median survival 54.3 months (95% CI: 25.7–82.9). No difference observed between two groups [resected: 25–83.6), unresected: 39.5 5.4–73.6); p = 0.74]. Upon analysis poor (HR 3.01; 95% CI 1.08–8.4; p = 0.035) a ≥10% 4.4; 1.2–16.1; p = 0.023) significant predictors Conclusions Resection does not significantly improve can be as symptomatic palliative therapy well-differentiated proliferative lower than 10%.

参考文章(28)
Pederzoli P, Contro C, Bonora A, Bassi C, Marcucci S, Sartori N, Salvia R, Falconi M, Cytoreductive surgery in advanced endocrine tumours of the pancreas. Italian Journal of Gastroenterology and Hepatology. ,vol. 31, pp. 207- 212 ,(1999)
Ilstrup Dm, van Heerden Ja, Thompson Gb, Grant Cs, Carney Ja, Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. ,vol. 104, pp. 1011- ,(1988)
Modlin Im, Lewis Jj, Bilchik Aj, Ahlman H, Kumar Rr, Management of unresectable malignant endocrine tumors of the pancreas. Surgery gynecology & obstetrics. ,vol. 176, pp. 507- 518 ,(1993)
Ronald S Chamberlain, David Canes, Karen T Brown, Leonard Saltz, William Jarnagin, Yuman Fong, Leslie H Blumgart, Hepatic neuroendocrine metastases: does intervention alter outcomes?11No competing interests declared. Journal of the American College of Surgeons. ,vol. 190, pp. 432- 445 ,(2000) , 10.1016/S1072-7515(00)00222-2
John G. Touzios, James M. Kiely, Susan C. Pitt, William S. Rilling, Edward J. Quebbeman, Stuart D. Wilson, Henry A. Pitt, Neuroendocrine hepatic metastases: does aggressive management improve survival? Annals of Surgery. ,vol. 241, pp. 776- 785 ,(2005) , 10.1097/01.SLA.0000161981.58631.AB
Juan M. Sarmiento, Michael B. Farnell, Florencia G. Que, David M. Nagorney, Pancreaticoduodenectomy for Islet Cell Tumors of the Head of the Pancreas: Long-term Survival Analysis World Journal of Surgery. ,vol. 26, pp. 1267- 1271 ,(2002) , 10.1007/S00268-002-6714-9
Vito Domenico Corleto, F Panzuto, Massimo Falconi, R Cannizzaro, S Angeletti, A Moretti, Gianfranco Delle Fave, Fabio Farinati, Oncology Study Section of the Italian Society of Gastroenterology, Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE). Digestive and Liver Disease. ,vol. 33, pp. 217- 221 ,(2001) , 10.1016/S1590-8658(01)80710-6
P Tomassetti, M Migliori, D Campana, E Brocchi, L Piscitelli, T Salomone, R Corinaldesi, Basis for treatment of functioning neuroendocrine tumours. Digestive and Liver Disease. ,vol. 36, ,(2004) , 10.1016/J.DLD.2003.11.012
Michael G House, Richard D Schulick, Endocrine tumors of the pancreas. Current Opinion in Oncology. ,vol. 18, pp. 23- 29 ,(2006) , 10.1097/01.CCO.0000198974.59239.3C